Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenues	$ 4,221	$ 4,621
Cost of revenues (including depreciation of $0 and $1 in the three months ended March 31, 2026 and 2025, respectively)	911	1,258
Gross profit	3,310	3,363
Operating expenses:
Selling and marketing	1,476	1,643
Research and development	1,848	2,857
General and administrative	2,113	2,724
Depreciation and amortization	1,246	1,349
Total operating expenses	6,683	8,573
Operating loss	(3,373)	(5,210)
Other income (expense):
Change in fair value of warrant liabilities	3	123
Interest expense, net	(526)	(25)
Other expense, net	(1)	(65)
Loss before provision for income tax	(3,897)	(5,177)
Provision for income tax expense	0	1
Net loss	$ (3,897)	$ (5,178)
Net loss per share – basic and diluted
Basic (in dollars per share)	$ (0.15)	$ (0.28)
Weighted average shares outstanding:
Weighted average shares outstanding – basic (in shares)	25,695	18,216